OUR TEAM
-
Harry Bushong
CEO and Managing Partner
Over 25 years of experience investing in and leading life sciences businesses.
-
Dr. Richard Mathies
Chief Technology Officer and Partner
Retired Dean of Chemistry, UC Berkeley. Authored 470+ publications and holds 40
patents in biophysical chemistry, photochemistry, and genome analysis technology. -
Blair Duncan
CFO and Partner
Brings 30+ years of expertise in venture-backed growth companies and Fortune 500 firms.
-
Robert Rabalais
CAO and Partner
Strategic legal advisor with deep experience in acquisition financings, working capital facilities, derivatives, and restructurings.
-
Martin Schmieg
Venture Partner
40+ years in leading life sciences initiatives and raising substantial capital across investor classes.
-
Dimitrios Karabatsos
Venture Partner
30+ years in asset management with extensive trading and leadership roles at top-tier banks, hedge funds, and family offices.
OUR EXPERIENCE
Our experience: Over the years, the Texas Life Ventures team has played a pivotal role in building and collaborating with many of the leading companies in the life sciences sector, including:
nanoTox/Material Intellect
Omnimmune Corp
Plurion
Zirius
Allopartis
BioRad
Celling Biosciences
Emergent Technologies
Cytometrics
Amphioxus
IntegenX
Optokey
Affymax
Caisson Biotech
AeonClad Coatings
ClearIt
NeoStem
Bennu Institute
Texas Water Development Board
Affymetrix
Molecular Dynamics
Aclara Biosciences
Nanostring
Freedom2
Isolagen
Sirna Therapeutics
Advanced Bionics Corporation
Pure Protein
Our Partnerships
We have worked with many companies who share our drive and desire to increase state venture capital. Some of these companies include:
MD Anderson Cancer Center (MDACC)
Translational research and development partner via executed Memorandum of Understanding (MOU)
Access to MDACC technology pipeline for investment (deal flow)
Cancer Prevention & Research Institute of Texas (CPRIT)
Non-dilutive capital co-investor
Due diligence, data, and analysis sharing
Deal flow
Texas Medical Center (TMC)
Incubator and accelerator opportunities
Deal flow
More to come...